Gene · 3021
NIH grants1,242
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 1,242
Download this page as JSON| Grant | Title | H3-3B papers | Newest fiscal year |
|---|---|---|---|
| R01GM140098 | Simulation of Multi-Protein systems | 1 | 2024 |
| R01NS110837 | Mechanisms and Modeling of Neuroblastoma-Associated ATRX Alterations | 1 | 2024 |
| R01NS117432 | Working towards targeted therapy in H3K27M tumors: Aurora Kinase Inhibitors and the role of epigenome programming | 1 | 2024 |
| R25GM086262 | University of Michigan Postbaccalaureate Research Education Program (UM PREP) | 1 | 2024 |
| R35DE027550 | Progenitor Regulation in Craniofacial Development and Regeneration | 1 | 2024 |
| R35GM138181 | Regulation and Function of Histone H3K36 Methylation in Mammalian Chromatin | 1 | 2024 |
| R37CA230042 | Investigation of NRF2-Dependent Metabolic Liabilities | 1 | 2024 |
| R50CA251960 | Improving the therapeutic efficacy of chemoradiation by targeting the DNA damage response | 1 | 2024 |
| RM1GM135136 | Solvation modeling for next-gen biomolecule simulations | 1 | 2024 |
| T32AI052077 | Basic Immunology Training Program | 1 | 2024 |
| T32GM007863 | Michigan Medical Scientist Training Program | 1 | 2024 |
| T35OD024982 | Training Veterinary Students for Careers in Biomedical Research | 1 | 2024 |
| U01CA246503 | Influence of Pre-Analytical Factors in Globlastoma MGMT Promoter Methylation Biomarker Assay | 1 | 2024 |
| U01CA260699 | Pipelines for Multiplexed FISH Chromatin Tracing data deposition, quality control, and sharing through the 4DN-Data Portal | 1 | 2024 |
| U24HG003345 | The Nomenclature of Human and Vertebrate Genes | 1 | 2024 |
| UL1TR001425 | Center for Clinical and Translational Science and Training | 1 | 2024 |
| UM1HG011536 | Center for 3D Structure and Physics of the Genome | 1 | 2024 |
| R01CA095641 | Chromatin's Role in Repair of Radiation-induced Damage | 5 | 2023 |
| R01GM037537 | Protein Sequencing by Tandem Mass Spectrometry | 5 | 2023 |
| T32GM007739 | Weill Cornell/Rockefeller/Sloan Kettering MST Program | 4 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3021/grants?page=17